CHINA PHARMA HOLDINGS, INC. Retained Earnings
CHINA PHARMA HOLDINGS, INC. (CPHI) had Retained Earnings of -$49.82 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-14
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$49.82M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$48.36M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$47.21M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$45.99M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$49.82M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | -$48.36M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | -$47.21M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | -$45.99M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | -$45.34M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | -$44.81M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | -$44.03M 10-K · filed 2026-04-01 | |
| 2024-09-30 | -$42.80M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | -$41.68M 10-Q · filed 2024-08-14 | |
| 2023-12-31 | -$39.29M 10-K · filed 2025-03-31 | |
| 2023-09-30 | -$38.06M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | -$37.28M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | -$36.69M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | -$36.21M 10-K · filed 2024-04-01 | |
| 2022-09-30 | -$34.95M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$34.16M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | -$33.27M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | -$32.24M 10-K · filed 2023-03-30 | |
| 2021-09-30 | -$31.26M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | -$30.43M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | -$29.61M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | -$28.84M 10-K · filed 2022-03-30 | |
| 2020-09-30 | -$27.63M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | -$26.62M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | -$26.63M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | -$25.97M 10-K · filed 2021-03-26 | |
| 2019-09-30 | -$7.23M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | -$6.53M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | -$5.69M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | -$5.27M 10-K · filed 2020-03-30 | |
| 2018-09-30 | $2.32M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $4.18M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $5.19M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $5.48M 10-K · filed 2019-03-28 | |
| 2017-09-30 | $19.31M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $21.50M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $23.79M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $24.76M 10-K · filed 2018-04-02 | |
| 2016-09-30 | $28.18M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $29.93M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $32.39M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $33.94M 10-K · filed 2017-03-31 | |
| 2015-09-30 | $40.19M 10-Q · filed 2015-12-28 | $46.61M 10-Q · filed 2015-11-16 |
| 2015-06-30 | $42.50M 10-Q · filed 2015-12-28 | $50.76M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $44.63M 10-Q · filed 2015-12-28 | $54.87M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $49.35M 10-K · filed 2016-03-30 | $62.85M 10-K · filed 2015-03-30 |
| 2014-09-30 | $71.54M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $77.86M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $86.51M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $88.90M 10-K · filed 2015-12-28 | |
| 2013-09-30 | $99.33M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $101.63M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $106.09M 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $108.90M 10-K · filed 2014-03-20 | |
| 2012-09-30 | $110.15M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $108.85M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $107.09M 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $104.29M 10-K · filed 2013-03-14 | |
| 2011-09-30 | $100.16M 10-Q/A · filed 2012-03-06 | $98.48M 10-Q · filed 2011-11-10 |
| 2011-06-30 | $95.19M 10-Q/A · filed 2011-09-06 | |
| 2010-12-31 | $85.02M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |